Many non-hospital healthcare providers such as clinics, urgent care facilities, and mobile health organizations are taking a closer look at how SafER’s low-cost, portable respiratory isolation systems are creating lucrative new revenue opportunities.
Providing nebulized medication treatments can potentially provide new revenue streams, however, until recently, these services could only be handled in negative pressure rooms because of the risk of fugitive particles that could escape and harm staff or other patients. Negative pressure rooms are costly, and require stringent protocols for depressurization, sanitization, and re-pressurization between patients.
The low-cost, easy-to-carry, six-pound SafER portable negative pressure system (PNPS) allows for several patients to be treated at once, even simultaneously. This inherent flexibility enables smaller service providers like clinics, urgent care facilities, and potentially even mobile home health providers to offer an expanded range of medication treatments without the huge expense of negative pressure rooms.
With SafER’s portable respiratory protection systems, smaller medical facilities can consider offering a variety of nebulized medications, such as Ribavirin, Dornase alfa, Pentamidine, Amphotericin B, Bronchodilators, Tobramycin, or Interferon. SafER’s PNPS is streamlined, lightweight, and offers 99.99% effective protection against the spread of fugitive airborne particles.
Read the full article on New Revenue Opportunities for Urgent Care and Clinics
